(Q28513856)

1

1 reference

25 January 2017

V. Stellmach

2

1 reference

25 January 2017

J. E. Murphy-Ullrich

3

1 reference

25 January 2017

S. M. Ribeiro

4

1 reference

25 January 2017

J. Lawler

5

1 reference

25 January 2017

R. O. Hynes

6

1 reference

25 January 2017

G. P. Boivin

7

1 reference

25 January 2017

N. Bouck

An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct

8

1 reference

25 January 2017

language of work or name

English

0 references

publication date

26 June 1998

1 reference

25 January 2017

1 reference

25 January 2017

93

1 reference

25 January 2017

1159–1170

1 reference

25 January 2017

7

1 reference

25 January 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Transforming growth factor-beta in disease: the dark side of tissue repair

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Insulin-like growth factor II/mannose 6-phosphate-receptor expression in liver and serum during acute CCl4 intoxication in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Type 1 transforming growth factor beta: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Regulation of proliferation and differentiation of respiratory tract epithelial cells by TGF beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Mechanism of retinoid-induced activation of latent transforming growth factor-? in bovine endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

The functions of thrombospondin and its involvement in physiology and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Control of junB and extracellular matrix protein expression by transforming growth factor-beta 1 is independent of simian virus 40 T antigen-sensitive growth-sensitive growth-inhibitory events

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Transforming growth factor-beta1-deficient mice: identification of isoform-specific activities in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Maternal rescue of transforming growth factor-beta 1 null mice

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Characterization of latent recombinant TGF-β2 produced by chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Tumor suppressor activity of the TGF-beta pathway in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

The transforming growth factor-beta family

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Transforming growth factor beta: a matter of life and death

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Structural characterization of the latent complex between transforming growth factor beta 1 and beta 1-latency-associated peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Regulation of differentiation by TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Latent transforming growth factor-beta: structural features and mechanisms of activation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Transforming growth factor-beta complexes with thrombospondin

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Transforming growth factor-beta 3 is required for secondary palate fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Tumor suppressor genes in the TGF-beta signaling pathway?

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

TGF-beta stimulates insulin secretion and blocks mitogenic response of pancreatic beta-cells to glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Thrombospondins selectively activate one of the two latent forms of transforming growth factor-beta present in adrenocortical cell-conditioned medium

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Transforming growth factor beta: the good, the bad, and the ugly

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Synthesis and expression of transforming growth factor beta-1, beta-2, and beta-3 in the endocrine and exocrine pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Role of carbohydrate structures in the binding of beta1-latency-associated peptide to ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-beta 1 chimeric gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981460-9

7 January 2021

10.1016/S0092-8674(00)81460-9

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1502474

1502474

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference